Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development
Source: Curia
Curia is known in the industry for its life-saving vaccines, breakthrough cancer treatments, steroids, rare-disease expertise, and overall small molecule and biologics development/manufacturing expertise with a 30+ year track record of success. Join Curia’s VP of Business Unit Operations – API, James Grabowski, to learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
This website uses cookies to ensure you get the best experience on our website. Learn more